Skip to content

News
 

CHI Board of Directors

George Scangos

CHI Chairman
George A. Scangos, Ph.D
President and CEO
Exelixis, Inc.

CHI President and CEO
David L. Gollaher, Ph.D.
California Healthcare Institute

Susan M. Baxter, Ph.D.

Chairman, Research and Education Sector Policy Committee
Susan M. Baxter, Ph.D.
Executive Director
California State University

David W. Beier
Senior Vice President, Global Government Affairs and Corporate Affairs
Amgen

John M. Dunn
Executive Vice President, New Ventures
Biogen Idec

Peter C. Farrell, Ph.D., DSc, AM
Executive Chairman of the Board
ResMed

David D. Fleming

David D. Fleming
Group Senior Vice President and Corporate Officer
Genzyme Corporation

Chairman, CHI Finance Committee
Lawrence P. Guiheen
President, BioPharmaceuticals
Baxter BioScience

Robert B. Hance

Chairman, Medical Technologies Sector Policy Committee
Robert B. Hance
President
Abbott Vascular

Carl W. Hull
President and Chief Executive Officer
Gen-Probe Incorporated

Chairman, CHI Audit Committee
Tracy T. Lefteroff
National Life Sciences Partner
PricewaterhouseCoopers

Marcea Lloyd

Marcea B. Lloyd
Senior Vice President
Government and Corporate Affairs and General Counsel
Amylin Pharmaceuticals, Inc.

Catherine Mackey

Catherine J. Mackey, Ph.D.
Senior Vice President
Pfizer

John C. Martin, Ph.D.
Chairman of the Board and CEO
Gilead Sciences

BOD - Peter Milner - sm

Peter G. Milner, M.D.
President, Co-Founder, Member Board of Directors
ARYx Therapeutics, Inc.

C.L. Max Nikias, Ph.D.
Executive Vice President and Provost
University of Southern California 

Christian W. Nolet
Partner and Life Sciences Industry Leader, West Region
Ernst & Young

Daniel ? y

Daniel O'Day
President and Chief Executive Officer
Roche Molecular Diagnostics

Michael Onuscheck

Michael Onuscheck
President and Senior Vice President, Neuromodulation
Boston Scientific

Richard P. Patrylak
Senior Vice President, Customer Sales, Marketing and Policy
Merck & Company

Philip A. Pizzo, M.D.
Dean of the School of Medicine
Stanford University

David E. I. Pyott
Chairman of the Board and CEO
Allergan 

BOD - William Rhodes - sm

William E. Rhodes
Worldwide President
BD Biosciences

John D. Stobo, M.D.
Senior Vice President for Health Sciences and Services
University of California

Katie M. Szyman
Senior Vice President and President, Diabetes
Medtronic Diabetes

Keith C. Valentine

Keith C. Valentine
President and Chief Operating Officer
NuVasive, Inc.

BOD - Thomas West - sm

Thomas A. West
Vice President, Metabolics Disease Group
Johnson & Johnson